| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0003 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.21 | 0.003 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.094 | 0.006 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.41 | 0.007 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.41 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |